Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Số trang: 14
Loại file: pdf
Dung lượng: 3.97 MB
Lượt xem: 14
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Patients with rheumatologic preexisting autoimmune disease (PAD) have not been enrolled in clinical trials of immune checkpoint inhibitors (ICIs). Therefore, the risks and benefits of ICI therapy in such patients are unclear. Herein, we investigated the safety and efficacy of ICIs in rheumatologic PAD patients through a meta-analysis.
Nội dung trích xuất từ tài liệu:
Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Nội dung trích xuất từ tài liệu:
Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Rheumatologic preexisting autoimmune diseases Immune checkpoint inhibitors Immune-related adverse events Meta-analysisTài liệu có liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 179 0 0 -
6 trang 171 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 150 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 135 0 0 -
12 trang 103 0 0
-
19 trang 81 0 0
-
17 trang 71 0 0
-
9 trang 48 0 0
-
9 trang 43 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 43 0 0